Adolor Corporation
Adolor Corporation Reports Year-End 2008 Financial Results
Published in Medical Letter on the CDC and FDA, March 15th, 2009
Net product sales of ENTEREG® (alvimopan) recognized for the quarter and year ended December 31, 2008 were approximately $1.1 million and $1.2 million, respectively. Under Adolor’s current revenue recognition policy, revenue related to a customer shipment is deferred until subsequent re-orders by that customer. For the year ended December 31, 2008, net product sales were recognized based on re-orders from approximately 185 hospitals. Total net shipments for the quarter and year ended December 31, 2008 were approximately $1.6 million and $2.2 million,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Scripps Research Institute
Scripps research scientists develop general-purpose method for detecting trace chemicals - Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals Reports Fourth Quarter and 2008 Financial Results - Aneurysm
Endovascular Repair Results in Decrease of Total Aneurysm Deaths - Breast Implants
Investigators at Allergan, Inc. have published new data on breast implants - Gout
New Report by BioTrends Research Group to Highlight the Launch of ULORIC(R) (febuxostat) - Life Sciences
Data from S. Tsai and colleagues advance knowledge in life sciences - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
